Navrongo Drug Options for IPT in Pregnancy Trial

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

3,642

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

February 28, 2007

Conditions

Malaria

Interventions

DRUG

Sulphadoxine-pyrimethamine

DRUG

Sulphadoxine-pyrimethamine, amodiaquine

Trial Locations (1)

Navrongo District Hosptial, Navrongo

All Listed Sponsors

collaborator

Ministry of Health, Ghana

OTHER_GOV

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00146783 - Navrongo Drug Options for IPT in Pregnancy Trial | Biotech Hunter | Biotech Hunter